Over the past 30 years, the majority of (pre) clinical efforts to find an effective therapy for
Alzheimer's disease (AD) focused on clearing the β-amyloid peptide (Aβ) from the brain …

S100B is a calcium-binding protein mainly concentrated in astrocytes in the nervous system.
Its levels in biological fluids are recognized as a reliable biomarker of active neural distress …

Neurodegenerative diseases (NDDs) like Alzheimer's disease (AD), Parkinson's disease
(PD), and amyotrophic lateral sclerosis (ALS) are defined by a myriad of complex …

Alzheimer's disease (AD) is a neurodegenerative disease that causes memory and cognitive
dysfunction and reduces a person's decision-making and reasoning functions. AD is the …

Traumatic Brain Injury (TBI) represents a significant health concern, necessitating advanced
therapeutic interventions. This detailed review explores the critical roles of astrocytes, key …

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive
loss of cognitive functions. While the exact causes of this debilitating disorder remain …

The discovery of effective therapeutics targeting amyloid-β (Aβ) aggregates for Alzheimer's
disease (AD) has been very challenging, which suggests its complicated etiology associated …

The Australian rainforest is a rich source of medicinal plants that have evolved in the face of
dramatic environmental challenges over a million years due to its prolonged geographical …

Alzheimer disease (AD) models are based on the notion that abnormal protein aggregation
is the primary event in AD, which begins a decade or longer prior to symptom onset, and …

Background Methamphetamine (METH) is a highly addictive stimulant that has become one
of the top five risk substances cause deaths from substance abuse. METH exposure …